C-reactive protein level and rate of detection of autoantibodies to β1-adrenoreceptors in patients with supraventricular tachyarrhythmias

Kardiologiya

Volumn 46, Issue 7, 2006, Pages 55-61

  Bekbosynova, M S ^a   Nikitina, T Ya ^a   Golitsin, S P ^a   Novikova, D S ^a   Loladze, N V ^a   Masenko, V P ^a   Tonevitsky, A G ^a  

^a NONE

Author keywords

Autoantibodies against 1 adrenoreceptors; Autoimune mechanisms; C reactive protein; Supraventricular tacky arrhythmias

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; C REACTIVE PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, BETA-1; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 33748863326     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bruins P., Velthuis H. et al. Activation of the complement system during and after cardiopulmonary bypass surgery. Circulation 1997;96:3542-3548.
2. Chung M.K., Martin D.O. et al. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistens of atrial fibrillation. Circulation 2001;104:2886-2891.
3. Darnellis J., Panaretou C. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001;56:375-380.
4. Acevedo M., Corbalan R. et al. C-reactive protein and atrial fibrillation: evidence of an inflammatory process in the initiation and perpetuation of the arrhythmia. Eur Heart J 2002;4:Abstr: Suppl:280.
5. Aviles R.J., Martin D.O. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010.
6. Liuzzo G., Biascussi I.M. et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996;94:2737-2741.
7. Milazzo D., Biasucci L.M. et al. Elevated levels of C-reactive protein before coronary artery bypass grafting predict reccurence of ischemic events. Am J Cardiol 1999;84:459-461.
8. Maixent J.M., Paganelli F., Scaglione J. et al. Antibodies against muosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:612-617.
9. Ristic A., Maisch B. Cardiac arrhythm and conduction disturbances: what is the role of autoimmune mechanisms? Herz 2000;3:181-188.
10. Chiale P., Rosenbaum M., Elizari M. et al. High prevalence of antibodies against beta1- and beta2-adrenoreceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 1995;26:864-869.
11. Chiale P., Calabrese F., Thiene G. et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation 2001;104:168-173.
12. Fucuda Y., Baba A., Yoshikawa T. et al. Anti-myocardial autoantibodies are found in patients with chronic lone atrial fibrillation. Sci Ses AHA 2002;abstract 2034.
13. Klein R., Maisch B., Lochsiek K. et al. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984;58:283-292.
14. Limas C.J., Goldenberg I.F., Limas C. Autoantibodies against β-adrenoreceptors in human idiopathic dilated cardiomyopathy. Circulat Res 1989;64:97-103.
15. Layer B., Padberg K., Schultheiss H. et al. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994;23:146-153.
16. Feldman A., McNamara D. Myocarditis. Circulation 2000;343:1388-1398.
17. Caforio A.L., Mahon N.J. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002;4:411-417.
18. Roberts W.L., Sedrick R., Moulton L., Spencer A. et al. Evaluation of Four Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Clin Chem 2000;46:4:461-468.
19. Pearson T., Mensah G. et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Am Heart Ass 2003;107:499-511.
20. Howard d. Sesso, Scott M. Grundy et al. Hypertension may be inflammatory disease. JAMA 2003;290:2945-2951.
21. Wallukat G. The beta-adrenergic Receptors. Herz 2002;27:683-690.
22. 1-adrenoceptor with positive chronotropic effect. Circulation 1994;89:2760-2767.
23. Ungerer M., Bohm M., Elce J. et al. Altered expression of β-adrenergic receptors kinase and β-adrenergic receptors in the failing human heart. Circulation 1993;87:454-464.
24. 1-adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocites. Mol Cell Cardiol 2001;33:515-525.
25. 1- adrenergic preceptor. FASEB J 2001;15:2718-2720.
26. 1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:418-424.
27. Matsui S., Fu M. et al. Peptides derived from cardiovascular C-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997;29:641-655.
28. 1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-654.